A medical research funding bill once again before Congress is among the promising developments for the 40 percent of U.S. women–including a particularly high number of African American women–who suffer adverse effects from uterine fibroids.
As rape survivors encounter problems getting emergency contraception at Catholic and even secular hospitals, health advocates express growing impatience with the FDA for not approving Plan B for over-the-counter sale.
Recently developed prenatal tests can detect genetic abnormalities and peg gender earlier than ever before. But some health advocates are concerned these tests could increase the number of selective abortions and even lead to “designer babies.”
Endometriosis affects 10 percent of U.S. women and can lead to infertility. Last weekend, researchers focused on new treatments for a disease that lacks a definitive cure.
During a public comment period that ends Nov. 1, advocates are pushing the acting FDA commissioner to ease over-the-counter access to emergency contraception. The previous FDA chief delayed access in August, then suddenly resigned on Sept. 23.
An estimated one-half of the more than 13,000 women who carried out emergency work at Ground Zero four years ago report health ailments. As Congress considers cutting aid for such responders, advocates cry foul.
Caesarean section, in which a baby is delivered by abdominal surgery, has increased fivefold in the past 30 years, prompting concern among health advocates who say vaginal delivery is in many cases a healthier option.
A growing number of women who once took hormone therapy are now taking black cohosh and eating soy foods to treat menopause. Major studies of the two therapies, however, are scrambling for needed funds.
Every 20 seconds, a woman contracts HIV, the infection that leads to AIDS. With a record 260,000 U.S. women living with this deadly disease, activists are battling to improve prevention and treatment.
This site uses cookies to provide you with a great user experience. By continuing to use this website, you consent to the use of cookies in accordance with our privacy policy.